WM-S1-030

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameWM-S1-030
Drug Alias NameWM-S1-030WM-S1-1030
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase inhibitors
TargetsReceptor protein-tyrosine kinase
Therapy Area/IndicationsSolid tumoursLung NeoplasmsHead and Neck Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWell Marker Bio
China Registration ClassN/A

Develop Information

Active CompaniesWell Marker Bio
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsHead and Neck Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A